Caesar BidCo GmbH,, a subsidiary of CVC Capital Partners plc (CVCCF.PK), Friday announced the final results of the public delisting offer to all shareholders of CompuGroup Medical SE & Co. KGaA, where CVC has secured a stake of approximately 27.78 percent.
The company further stated that the Administrative Board of CompuGroup Medical will expand from five to six members, reflecting the terms of the Investment Agreement with CVC, effective July.
Notably, the public delisting of CompuGroup Medical from the Frankfurt Stock Exchange has become effective as of expiry of June 24, 2025.
Following this, shareholders of CompuGroup Medical who tendered their shares in the public delisting offer will be paid the offer price of 22 euros per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.